Clinical Trials in Austin

Showing 61-80 of 13,060 trials

A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia

NCT02477020

The purpose of this study is to evaluate the efficacy, safety and tolerability of TAK-063 compared with placebo in treatment of acutely exacerbated schizophrenia.

Schizophrenia

Takeda164 participantsStarted Jul 2015

Springdale, Alaska, United States • Culver City, California, United States • Lemon Grove, California, United States +12 more locations

RECRUITINGPhase 3< 1 mile

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

NCT06919965

The main purpose of this study is to compare the disease-free survival (the length of time after randomization that a participant survives without any signs or symptoms of the cancer returning, or progressing) between Bacillus Calmette-Guérin (BCG) treated participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of high-risk non-muscle-invasive bladder cancer (HR-NMIBC).

Non-Muscle Invasive Bladder Neoplasms

Janssen Research & Development, LLC220 participantsStarted Sep 2025

Lakewood, Colorado, United States • Atlanta, Georgia, United States • Chicago Ridge, Illinois, United States +105 more locations

A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

Find Trials by Condition in Austin

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Radiprodil in Participants With Hepatic Impairment

A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

Acute Normovolemic Hemodilution in High Risk Cardiac Surgery Patients.

Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis

A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

STrategies for Catheter Ablation of peRsistent Atrial Fibrlllation